Michael Shipton
Corporate Officer/Principal chez SCIENCE 37 HOLDINGS, INC.
Profil
Michael Shipton's career history includes current and former positions as well as his education background.
Currently, he is the Chief Commercial Officer at Science 37 Holdings, Inc. Prior to this, he held the position of Senior VP-Customer Solutions & Strategy at Syneos Health, Inc. from 2021 to 2022.
Before that, he worked as the Senior Director & Global Head-Strategic Pricing at Quintiles Transnational Holdings, Inc. Mr. Shipton completed his undergraduate degree at North Carolina State University and obtained an MBA from Pfeiffer University.
Postes actifs de Michael Shipton
| Sociétés | Poste | Début |
|---|---|---|
| SCIENCE 37 HOLDINGS, INC. | Corporate Officer/Principal | 12/09/2022 |
Anciens postes connus de Michael Shipton
| Sociétés | Poste | Fin |
|---|---|---|
| SYNEOS HEALTH, INC. | Corporate Officer/Principal | 01/01/2022 |
Quintiles Transnational Holdings, Inc.
 Quintiles Transnational Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Formation de Michael Shipton
| North Carolina State University | Undergraduate Degree |
| Pfeiffer University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SCIENCE 37 HOLDINGS, INC. | Commercial Services |
| Entreprise privées | 2 |
|---|---|
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
Quintiles Transnational Holdings, Inc.
Quintiles Transnational Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC. | Commercial Services |
